Literature DB >> 17149387

Genetic screening for autosomal recessive nonsyndromic mental retardation in an isolated population in Israel.

Lina Basel-Vanagaite1, Ellen Taub, Gabrielle J Halpern, Valerie Drasinover, Nurit Magal, Bella Davidov, Joël Zlotogora, Mordechai Shohat.   

Abstract

Nonsyndromic mental retardation (NSMR) is the diagnosis of exclusion in mentally retarded individuals without additional abnormalities. We have recently identified a protein-truncating mutation, G408fsX437, in the gene CC2D1A on chromosome 19p13.12 in nine consanguineous Israeli Arab families with severe autosomal recessive NSMR, and have developed a comprehensive prevention program among the at-risk population in the village. The subjects tested were healthy women who were invited to undergo the genetic screening test as a part of their routine pregnancy monitoring. One hundred and seventeen subjects reported a family history positive for mental retardation. We tested 524 pregnant or preconceptional women and found 47 carriers (approximately 1/11), whose spouses were then recommended to undergo testing. We identified eight carrier couples, who were given genetic counseling and offered prenatal diagnosis. Of all the marriages, 28.6% were consanguineous; 16.5% of the total were between first cousins. The high prevalence of the mutation can be explained both by the founder effect owing to the generally high consanguinity rate among the inhabitants of the village, and also because two families with excessive numbers of mentally retarded offspring were unacceptable as marriage partners by the rest of the families. This is the first example of the establishment of a large-scale genetic screening program for autosomal recessive NSMR, which was made possible owing to the high frequency of the specific causative mutation in this isolated population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17149387     DOI: 10.1038/sj.ejhg.5201750

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  A targeted population carrier screening program for severe and frequent genetic diseases in Israel.

Authors:  Joël Zlotogora; Rivka Carmi; Boaz Lev; Stavit A Shalev
Journal:  Eur J Hum Genet       Date:  2008-12-24       Impact factor: 4.246

2.  Genetics of intellectual disability in consanguineous families.

Authors:  Hao Hu; Kimia Kahrizi; Hans-Hilger Ropers; Hossein Najmabadi; Luciana Musante; Zohreh Fattahi; Ralf Herwig; Masoumeh Hosseini; Cornelia Oppitz; Seyedeh Sedigheh Abedini; Vanessa Suckow; Farzaneh Larti; Maryam Beheshtian; Bettina Lipkowitz; Tara Akhtarkhavari; Sepideh Mehvari; Sabine Otto; Marzieh Mohseni; Sanaz Arzhangi; Payman Jamali; Faezeh Mojahedi; Maryam Taghdiri; Elaheh Papari; Mohammad Javad Soltani Banavandi; Saeide Akbari; Seyed Hassan Tonekaboni; Hossein Dehghani; Mohammad Reza Ebrahimpour; Ingrid Bader; Behzad Davarnia; Monika Cohen; Hossein Khodaei; Beate Albrecht; Sarah Azimi; Birgit Zirn; Milad Bastami; Dagmar Wieczorek; Gholamreza Bahrami; Krystyna Keleman; Leila Nouri Vahid; Andreas Tzschach; Jutta Gärtner; Gabriele Gillessen-Kaesbach; Jamileh Rezazadeh Varaghchi; Bernd Timmermann; Fatemeh Pourfatemi; Aria Jankhah; Wei Chen; Pooneh Nikuei; Vera M Kalscheuer; Morteza Oladnabi; Thomas F Wienker
Journal:  Mol Psychiatry       Date:  2018-01-04       Impact factor: 15.992

3.  The roles of CC2D1A and HTR1A gene expressions in autism spectrum disorders.

Authors:  Elif Funda Sener; Merve Cıkılı Uytun; Keziban Korkmaz Bayramov; Gokmen Zararsiz; Didem Behice Oztop; Halit Canatan; Yusuf Ozkul
Journal:  Metab Brain Dis       Date:  2016-01-19       Impact factor: 3.584

4.  Homozygous MED25 mutation implicated in eye-intellectual disability syndrome.

Authors:  Lina Basel-Vanagaite; Pola Smirin-Yosef; Jenna Lee Essakow; Shay Tzur; Irina Lagovsky; Idit Maya; Metsada Pasmanik-Chor; Adva Yeheskel; Osnat Konen; Naama Orenstein; Monika Weisz Hubshman; Valerie Drasinover; Nurit Magal; Gaby Peretz Amit; Yael Zalzstein; Avraham Zeharia; Mordechai Shohat; Rachel Straussberg; Didier Monté; Mali Salmon-Divon; Doron M Behar
Journal:  Hum Genet       Date:  2015-03-20       Impact factor: 4.132

Review 5.  The molecular basis of autosomal recessive diseases among the Arabs and Druze in Israel.

Authors:  Joël Zlotogora
Journal:  Hum Genet       Date:  2010-09-18       Impact factor: 4.132

6.  Consanguinity and birth defects in the jerusalem perinatal study cohort.

Authors:  S Harlap; K Kleinhaus; M C Perrin; R Calderon-Margalit; O Paltiel; L Deutsch; O Manor; E Tiram; R Yanetz; Y Friedlander
Journal:  Hum Hered       Date:  2008-05-20       Impact factor: 0.444

Review 7.  Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases.

Authors:  A H Bittles; M L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

8.  Bi-allelic Loss-of-Function Variants in DNMBP Cause Infantile Cataracts.

Authors:  Muhammad Ansar; Hyung-Lok Chung; Rachel L Taylor; Aamir Nazir; Samina Imtiaz; Muhammad T Sarwar; Alkistis Manousopoulou; Periklis Makrythanasis; Sondas Saeed; Emilie Falconnet; Michel Guipponi; Constantin J Pournaras; Maqsood A Ansari; Emmanuelle Ranza; Federico A Santoni; Jawad Ahmed; Inayat Shah; Khitab Gul; Graeme Cm Black; Hugo J Bellen; Stylianos E Antonarakis
Journal:  Am J Hum Genet       Date:  2018-10-04       Impact factor: 11.025

9.  A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability.

Authors:  Muzammil Ahmad Khan; Muhammad Arshad Rafiq; Abdul Noor; Nadir Ali; Ghazanfar Ali; John B Vincent; Muhammad Ansar
Journal:  BMC Med Genet       Date:  2011-04-22       Impact factor: 2.103

10.  Consanguineous Marriage and Intellectual and Developmental Disabilities among Arab Bedouins Children of the Negev Region in Southern Israel: A Pilot Study.

Authors:  Hassan Abu Saad; Salman Elbedour; Eyad Hallaq; Joav Merrick; Ariel Tenenbaum
Journal:  Front Public Health       Date:  2014-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.